Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)
June 28 2018 - 3:19PM
Edgar (US Regulatory)
Prospectus Supplement No. 7
(to Prospectus dated December 1, 2017)
|
Filed Pursuant to Rule 424(b)(3)
Registration No. 333-221792
|
102,255,099 Shares
This prospectus supplement
updates and supplements the prospectus dated December 1, 2017 (the “Prospectus”), which forms a part of our Registration
Statement on Form S-1, as amended (Registration No. 333-221792). This prospectus supplement is being filed to update and supplement
the information in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and
Exchange Commission on June 28, 2018 (the “Current Report”). Accordingly, we have attached the Current Report to this
prospectus supplement.
The Prospectus relates
to the offer and sale of 102,255,099 ordinary shares, par value $0.0001 per share (“Ordinary Shares”) by existing holders
of the Ordinary Shares named in the Prospectus.
This prospectus supplement
should be read in conjunction with the Prospectus. This prospectus supplement updates and supplements the information in the Prospectus.
If there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the
information in this prospectus supplement.
Our Ordinary Shares
are listed on the New York Stock Exchange under the symbol “CISN”. On June 27, 2018, the closing price of our Ordinary
Shares was $14.45.
Investing in our
Ordinary Shares involves risks that are described in the “Risk Factors” section beginning on page 7 of the Prospectus,
page 15 of our Annual Report on Form 10-K and under similar headings in any further amendments or supplements to the Prospectus.
Please review these risks before you decide whether to invest in our securities.
Neither the Securities
and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if the
Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is
June 28, 2018.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
June 26, 2018
CISION LTD.
(Exact Name of Registrant as Specified in
Charter)
Cayman Islands
(State or Other Jurisdiction
of Incorporation)
|
000-38140
(Commission
File Number)
|
N/A
(IRS Employer
Identification No.)
|
130 East Randolph Street, 7th Floor
Chicago, Illinois
(Address of Principal Executive Offices)
|
60601
(Zip Code)
|
Registrant’s telephone number, including
area code:
866-639-5087
N/A
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13c-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
x
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 5.07
|
Submission of Matters to a Vote of Security Holders.
|
On June 26, 2018, Cision Ltd. (the “Company”)
held its 2018 Annual General Meeting of Shareholders. Holders representing 126,526,732 ordinary shares of a total of 130,470,400
ordinary shares outstanding as of the record date were present at the meeting in person or by proxy. Votes were cast as follows:
Proposal 1: Election of directors
Each of the following directors received
the affirmative vote of a majority of the votes cast at the Annual General Meeting at which a quorum was present, and were elected
for a three-year term expiring at the Company's 2021 Annual Meeting or until their respective successors are duly elected and qualified.
Nominee
|
For
|
Against
|
Abstain
|
Broker Non-Vote
|
|
Stephen P. Master
|
103,683,109
|
18,786,351
|
190,118
|
3,867,154
|
|
L. Dyson Dryden
|
119,606,680
|
2,862,780
|
190,118
|
3,867,154
|
|
Proposal 2: Ratification of appointment of PricewaterhouseCoopers
LLP as Cision Ltd.’s independent registered public accounting firm for the year ending December 31, 2018
The Company's shareholders ratified the
appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for the year ending December 31, 2018.
|
|
|
|
|
For
|
Against
|
Abstain
|
|
125,661,014
|
0
|
865,718
|
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: June 28, 2018
|
CISION LTD.
|
|
|
|
|
By:
|
/s/ Jack Pearlstein
|
|
|
|
Name: Jack Pearlstein
|
|
|
Title: Chief Financial Officer
|
Cision (NYSE:CISN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cision (NYSE:CISN)
Historical Stock Chart
From Jul 2023 to Jul 2024